Reviva Pharmaceuticals Holdings Inc Reports Q3 2024 GAAP EPS of -0.25 with Net Loss of 8.4 Million
RVPH Stock | USD 1.99 0.10 5.29% |
Under 67 percent of all Reviva Pharmaceuticals' traders are curious in acquiring. The analysis of the overall investor sentiment regarding Reviva Pharmaceuticals Holdings suggests that a large number of traders are confidant. Reviva Pharmaceuticals' investing sentiment shows overall attitude of investors towards Reviva Pharmaceuticals Holdings.
Reviva |
Net Loss Reported a net loss of approximately 8.4 million for Q3 2024, an improvement from the 11.3 million loss in Q3 2023.Earnings Per Share GAAP E
Read at gurufocus.com
Reviva Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Reviva Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Reviva Pharmaceuticals Fundamental Analysis
We analyze Reviva Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reviva Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reviva Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Reviva Pharmaceuticals is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Reviva Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reviva Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reviva Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reviva Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reviva Pharmaceuticals Related Equities
FBIO | Fortress Biotech | 2.25 | ||||
PLX | Protalix Biotherapeutics | 0.41 | ||||
ACAD | ACADIA Pharmaceuticals | 0.80 | ||||
CABA | Cabaletta Bio | 1.26 | ||||
UNCY | Unicycive Therapeutics | 1.64 | ||||
ZVSA | ZyVersa Therapeutics | 2.16 | ||||
CUE | Cue Biopharma | 2.76 | ||||
INAB | In8bio | 3.85 | ||||
LTRN | Lantern Pharma | 5.66 | ||||
ATHA | Athira Pharma | 5.66 | ||||
EYPT | Eyepoint Pharmaceuticals | 6.27 | ||||
SLS | Sellas Life | 8.64 |
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |